Our genetic heritage is not a blueprint or an algorithm, as many biologists have imagined, but something else entirely.

In her first year of graduate school at Stanford University, back in 2021, Sydney Erickson knew only that she was going to be a physicist. Now Erickson is finishing her doctoral degree and ...

The technology that gave the world mRNA COVID vaccines is being tested in a variety of new ways, and emerging research ...

A sweeping global review led by researchers at the University of British Columbia has found that mRNA vaccines—now administered billions of times worldwide—are safe and highly effective at preventing ...

The same family of artificial intelligence that powers today's image generators is now being aimed at one of biology's ...

Although gene therapy has shown promise for the treatment of Duchenne muscular dystrophy (DMD), the limitations of viral vectors have proven challenging to clinical advancement. Now, a new treatment ...

Design Therapeutics has its proprietary GeneTAC platform, which gives them a small-molecule way to target repeat-expansion ...

With a market cap of $19.5 billion, Moderna, Inc. (MRNA) is a biotechnology company focused on developing medicines and vaccines using messenger RNA (mRNA) technology. Headquartered in Cambridge, ...

Good afternoon, everyone. Thank you so much for joining us. It's my pleasure to introduce Moderna. And with us, we have Jamey Mock, CFO. Jamey, thanks for joining us. Yes. Great. Well, again, thanks ...